|
Tuberculosis |
Testing for TB Disease and Infection
TB should be considered in any patient who has:
A cough, persistent for 3 weeks.
Groups who should be tested
Skin testing for tuberculosis is useful in countries where
the incidence of tuberculosis is low, and the
health care system works well to detect and treat new cases.
In countries where BCG vaccination has been widely used,
the TB skin test is not useful, because persons
vaccinated with BCG will have a positive skin test.
The TB skin test is based upon the type 4 hypersensitivity
reaction. If a previous TB infection has occurred,
there are sensitised lymphocytes that can react
to another encounter with antigens from TB organisms.
For the TB skin test, a measured amount of tuberculin
purified protein derivative (PPD) is injected
intracutaneously to form a small wheal, typically
measured on the forearm. In 48 to 72 hours, a positive
reaction is marked by an area of red induration that can
be measured by gentle palpation (redness from itching
and scratching doesn't count). Reactions over 10 mm
in size are considered positive in non-immunocompromised
persons.
Within 48 - 72 hours, a positive skin test is marked
by an area of reddish induration greated than 10mm. It is the
induration(firm bump) that is gently palpated that determines
the size, not the area of redness. This reaction is slightly larger
than the average positive test. This one is 17mm in size.
The positive reaction shown here was obtained with a TB
skin test performed 20 years after the initial infection.
Repeated testing may increase the size of the reaction (induration),
but repeated TB skin testing will not lead to a positive
test in a person not infected by TB. Anergy, or absence of PPD
reactivity in persons infected with TB, can occur
in immunocompromised persons, or it may even occur
in persons newly infected with TB, or in persons
with miliary TB.
Tuberculin Skin Testing


